This switch can be mitigated, however, by using a nasogastric tube for direct gastrointestinal access or by taking the medication with sodas or juice to make the medication more tolerable
The findings were presented at the th st EASD Annual Meeting 2025, held from 15-19 September 2025 in Vienna, Austria ADA recommendations include GLP-1RAs in people with high-risk T2D with CV or kidney disease
Interestingly, only about 0.2% of patients reported injection-site reactions during clinical studies
However, maintaining weight loss after treatment ends remains a major challenge
Ethics statement The studies involving humans were approved by Ethics Committee of Second Affiliated Hospital, Zhejiang University School of Medicine
Dynasty Clinic provides expert guidance for those considering Ipamorelin therapy, ensuring safe and effective use